Our approach.
Cancer is often considered a metabolic disease with citrate as the main substrate in energy and building block synthesis.
metaThera research focuses on citrate metabolism, uptake and signaling in metastatic cancer cells. We concentrate on finding small molecule inhibitors for pmCiC and through reduced extracellular citrate uptake dysregulate cancer metabolism, reduce therapy resistance and target metastasis.